Table 2. The schedule of clinical trial

Period - Treatment phase Follow-up phase
Visit Screening 1 2 3
Week -10 D 0 1 2
Consent
Demographic investigation
Medical history
Vitals sign
Body measurement
Clinical laboratory test
Criteria of selection and exception
Korean medical demonstrative classification
Randomization
Providing cream
PSS
Skindex-29
Corneometer
Tewameter
Testing abnormal response
Clarification of medicine
Site Visit education